Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03868631 · ClinicalTrials.gov registry record · NA
Muscle Growth Following a Resistance Training Program in Men and Women Consuming Protein Supplements
A NA study, sponsored by Point Loma Nazarene University.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
NCT03868631: Completed NA study, sponsored by Point Loma Nazarene University.
NCT03868631 is a NA study that has completed, run by Point Loma Nazarene University. The registered enrollment target is 61 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03868631, a NA study, has completed, sponsored by Point Loma Nazarene University.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
Study Summary
Soy and whey protein have different concentrations of leucine, an amino acid known to be a particularly potent simulator of muscle protein synthesis. The purpose of this study is to determine whether matching soy and whey protein supplements for leucine content instead of by total protein content would contribute to differences in strength increases and muscle growth in response to 12 wk of resistance training.
Primary Outcome
assessed using dual energy x-ray absorptiometry (DEXA) scan for changes in lean body mass (kg)
Interventions
- DIETARY_SUPPLEMENT Whey protein supplement
- DIETARY_SUPPLEMENT Soy protein supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2016-08-15 |
| Est. Completion | 2017-04-30 |
| Phase | NA |
What the finished NCT03868631 record still lists
NCT03868631 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Whey protein supplement is the first listed.
NCT03868631 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03868631 about?
NCT03868631 is a clinical study titled "Muscle Growth Following a Resistance Training Program in Men and Women Consuming Protein Supplements". Soy and whey protein have different concentrations of leucine, an amino acid known to be a particularly potent simulator of muscle protein synthesis. The purpose of this study is to determine whether matching soy and whey protein supplements for leucine content instead of by total protein content wo...
What is the current status of trial NCT03868631?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2016-08-15. Estimated completion is 2017-04-30.
What interventions are being tested in trial NCT03868631?
The interventions under investigation include: Whey protein supplement (DIETARY_SUPPLEMENT), Soy protein supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03868631?
This trial is sponsored by Point Loma Nazarene University, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03868631's enrollment target sits among peer trials
61 1164th of 2000 higher than 837 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI